University of Patras
Η συμμετοχή του υποδοχέα CD44 και των βιοσυνθετικών και καταβολικών ενζύμων του υαλουρονικού οξέος στον καρκίνο του παχέος εντέρου
Abstract
dc:descriptionColon cancer comes third worldwide in men and fourth in women. During progression to colon cancer, the first disorder observed is the increase of the cells number (hyperplasia) at the intestinal epithelial surface. As a result, adenomas formed increase in size and number, without invading in neighboring structures. Some of the adenomas can become in situ cancer and finally invasive cancer. Extracellular matrix surrounds the cells and supports their growth into the tissues. Particularly, the molecules of the extracellular matrix interact with the cells, signal them and affect important cellular functions, such as recognition between cells, cell adhesion, migration, proliferation and differentiation. In cancer, structural changes take place in the synthesis and degradation of the extracellular matrix, leading to increased deposition of molecules in the matrix. As normal cells become cancerous, the extracellular matrix is modified in such a way that promotes the secretion of molecules, which further promote the growth of cancer cells and promote processes such as filtration and metastasis. The extracellular matrix, therefore, is one that provides in tumor cells survival signals, such as proliferation, motility, infiltration and metastasis. Hyaluronan is a main component of the extracellular matrix, which participates in a variety of molecular functions, which contribute both to structural features of the tissue and on the cell behavior during the formation or reorganization of tissues. Most cancers are characterized by an increased accumulation of hyaluronan. In most normal biological processes, large molecules of hyaluronan are usually found, whereas in cancerous conditions small molecules of hyaluronan are mostly found, which are considered to facilitate the mobility of cancer cells and infiltration. In the production of molecules of hyaluronan, its biosynthetic enzymes play catalytic role, hyaluronan synthases (HAS1, HAS2, HAS3), and its catabolic enzymes, hyaluronidases (Hyal-1, -2, -3, PH-20). The three synthases, while they have high homology in their sequence, they differ in the sizes of synthesized molecules. Hyaluronidases have also high degree of homology, they are transcriptionally active and their expression depends on the type of tissue in which they are expressed. During tumor development differential expression of synthases is observed and the transcriptional regulation of genes allows the cells to modulate the extracellular environment so as to favor tumor growth and metastasis. Additionally, numerous studies show differential hyaluronidase expression in cancer, which suggests that cancer cells use hyaluronidase to cleave hyaluronan in tissues and thereby facilitate tumor invasion. Furthermore, loss of hyaluronolytic activity leads to accumulation of hyaluronan that may be one of the steps required by the cells during carcinogenesis. All these molecules are involved in hyaluronan metabolism and in the reorganization of the extracellular matrix, in cell-extracellular matrix interactions and are likely critical factors in the development of disease. Based on the above data and the extensive studies carried out on the involvement of hyaluronan mechanisms in evolution, infiltration and metastasis of many types of cancer, the aim of this study was to study the stage-dependent expression, at transcriptional and protein level, of the molecules associated with the metabolism of hyaluronan (hyaluronan synthases, hyaluronidases, cellular receptor-CD44) in colorectal cancer. At the present study we examined the involvement of hyaluronan synthases (HAS1, HAS2, HAS3), of hyaluronidases [Hyal-1, -2, -3, PH-20, Hyal-1(V2-V5) and Hyal-3(V2-V3)] and of hyaluronan receptor (CD44s και CD44-variants) in different cancerous stages of colon cancer. We studied their expression at mRNA and protein level in macroscopically normal and cancerous tissues and in colon cancer cell lines. Expression of the molecules was confirmed by immunohistochemical analysis. During tumor progression, the actions of hyaluronan synthases and hyaluronidases lead to the production of low or high molecular mass hyaluronan molecules, each one having the ability to bind CD44 and regulate in a different way its activity. Moreover, the existence of post-translational modifications and alternative splicing of the receptor confers even greater complexity in his action. In colorectal cancer it has been shown, in vitro and in vivo, correlation between the receptor activity and the action of the metabolic enzymes of hyaluronan, where overexpression of HAS2 gene leads to faster growth of cancer cells, while overexpression of Hyal-1 gene suppresses the growth rate of cancer cells. The studies carried out in this thesis associate the overexpression of HAS2 gene with down-regulation of Hyal-1 and CD44 gene with cancer stage progression. Moreover, the loss of protein expression of Hyal-1, -2 and -3 along with the overexpression of HAS1 and HAS3 genes at initial tumor stages confers the cancerous cells hyaluronan rich environment that stimulates growth, motility and metastatic spread. Hyaluronan molecules accumulate in the matrix and lead to the formation of networks bridging CD44 molecules being expressed by cancer cells, they bind CD44 and thereby lead to signaling pathways that promote the development of colorectal cancer. Alternative splicing of the receptor gives great complexity in the above actions. The differential expression of particular alternatively spliced isoforms in the metastatic cancer cell lines, firstly confirms the alternative splicing of the receptor in cancer, and secondly relates the aggressiveness of colorectal cancer with certain isoforms (CD44v3, v7-v10, v8-v9 , v8-v10), the expression of which is affected differently by the presence or absence of serum. Knowing that growth factors and cytokines, released from the tumor cells, trigger signaling events which enhance the deposition of molecules in the extracellular space and activate the expression of CD44 by the tumor cells, it is concluded that the expression of these isoforms at high metastatic cells is favored by the presence of these factors in serum. The synthesis and degradation of different molecules of hyaluronan by their metabolic enzymes lead to interaction with the receptor, which according to the needs of cancer cells express alternatively spliced isoforms and undergo modifications in order to facilitate their actions. These processes provide extreme complexity in the behavior of the system hyaluronan synthase-hyaluronidase-hyaluronan receptor and thereby it is necessary to clarify the mechanisms that promote the metastatic phenotype of colon cancer. Finally, considering that some of these molecules have been proposed as predictors (Hyal-1, HAS1) and tumor (CD44) markers in other types of cancers, as well as complementary cancer therapies (PH-20), we propose their application in diagnosis and treatment of colon cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bouga, Eleni
- Μπούγα, Ελένη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37904